找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Quantitative Decisions in Drug Development; Christy Chuang-Stein,Simon Kirby Book 2021Latest edition The Editor(s) (if applicable) and The

[复制链接]
楼主: Fillmore
发表于 2025-3-26 21:27:18 | 显示全部楼层
A Frequentist Decision-Making Framework,. Procedures for assessing evidence and making decisions under the Frequentist approach are calibrated by how they would perform were they used repeatedly. We discuss challenges associated with the interpretation of .-values in the presence of multiplicity and selective inference.
发表于 2025-3-27 04:48:33 | 显示全部楼层
发表于 2025-3-27 08:15:58 | 显示全部楼层
发表于 2025-3-27 11:08:53 | 显示全部楼层
Characteristics of a Diagnostic Test,view the metrics commonly used to characterize the performance of a diagnostic test. We then discuss what it means when a diagnostic test returns a positive or a negative result. We illustrate the discussion with the use of several decision rules.
发表于 2025-3-27 17:31:58 | 显示全部楼层
Clinical Testing of a New Drug,d for emergency use through extensive public–private partnerships and the adoption of a high-risk business model. We offer some examples of recent advances in clinical trial designs and conclude the chapter with a short summary of the salient points covered in the chapter.
发表于 2025-3-27 20:31:14 | 显示全部楼层
The Parallel Between Clinical Trials and Diagnostic Tests,reproducibility is briefly discussed. We end the chapter by highlighting the difference between statistical power and the probability of a positive trial. This last point becomes more important as a new drug moves through the various development stages as will be illustrated in Chap. ..
发表于 2025-3-28 00:00:19 | 显示全部楼层
Designing Proof-of-Concept Trials with Desired Characteristics, can be considered as special cases of the LPDAT approach. We review the metrics introduced in Chap. . in the context of these five design types. We show how prior information on historical controls can be used to help plan a POC study and share an example on this application involving a rare disease.
发表于 2025-3-28 05:40:17 | 显示全部楼层
Designing Confirmatory Trials with Desired Characteristics,e hypothesis-testing perspective. In addition, we discuss factors that could affect POSS and how these factors should be incorporated into the planning of the confirmatory program. The chapter highlights the importance of a robust investment in Phase 2 development in order to achieve a desirable level of POSS at the Phase 3 stage.
发表于 2025-3-28 09:53:09 | 显示全部楼层
发表于 2025-3-28 11:50:51 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-3 02:23
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表